Works matching IS 27506665 AND DT 2024 AND VI 3 AND IP 3/4

Results: 8

Elevated cerebral oxygen extraction in patients with post-COVID conditions.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 169, doi. 10.1515/nipt-2024-0014

By:

Liu, Peiying;
Ernst, Thomas;
Liang, Huajun;
Jiang, Dengrong;
Cunningham, Eric;
Ryan, Meghann;
Lu, Hanzhang;
Kottilil, Shyamasundaran;
Chang, Linda

Publication type:

Article

Frontmatter.

Published in:: NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. i, doi. 10.1515/nipt-2024-frontmatter3-4
Publication type:: Article

The challenges to detect, quantify, and characterize viral reservoirs in the current antiretroviral era.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 211, doi. 10.1515/nipt-2024-0017

By:

Gutierrez, Hector;
Eugenin, Eliseo A.

Publication type:

Article

Build muscles and protect myelin.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 175, doi. 10.1515/nipt-2024-0015

By:

Bose, Ahana;
Pahan, Kalipada

Publication type:

Article

Motivational dysregulation with melanocortin 4 receptor haploinsufficiency.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 237, doi. 10.1515/nipt-2024-0011

By:

Steiner, Alex M.;
Roscoe Jr., Robert F.;
Booze, Rosemarie M.;
Mactutus, Charles F.

Publication type:

Article

Sedation with midazolam in the NICU: implications on neurodevelopment.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 195, doi. 10.1515/nipt-2024-0009

By:

Nguyen, Nghi M.;
Pendyala, Gurudutt

Publication type:

Article

Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 221, doi. 10.1515/nipt-2024-0008

By:

Qayum, Sana;
Schmitt, Rebecca R.;
Machhar, Janvhi S.;
Garg, Sonali;
Bass, Caroline;
Muthaiah, Vijaya P. K.;
Ignatowski, Tracey A.;
Mahajan, Supriya D.

Publication type:

Article

Cannabis use, oral dysbiosis, and neurological disorders.

Published in:

NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 3/4, p. 183, doi. 10.1515/nipt-2024-0012

By:

Hazzard, Amber A.;
McCrorey, Marice;
Salman, Tabinda;
Johnson, Douglas E.;
Luo, Zhenwu;
Fu, Xiaoyu;
Keegan, Andrew P.;
Benitez, Andreana;
Fitting, Sylvia;
Jiang, Wei

Publication type:

Article